BLUEPRINT MEDICINES CORPORATION Increase (Decrease) in Other Noncurrent Liabilities
BLUEPRINT MEDICINES CORPORATION reported Increase (Decrease) in Other Noncurrent Liabilities of -$12.23 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2025-02-13
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2024-12-31 was -$6.03M.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2024-09-30 was -$4.33M, a 144266.67% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2023-12-31 was -$5.00K.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2023-09-30 was $3.00K.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$12.23M.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$7.24M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$10.36M derived: sum of 2 quarters · filed 2025-02-13 | -$12.23M 10-K · filed 2025-02-13 | |
| 2024-09-30 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$6.20M 10-Q · filed 2024-10-30 | ||
| 2024-06-30 | -$1.87M 10-Q · filed 2024-08-01 | |||
| 2023-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$2.00K derived: sum of 2 quarters · filed 2025-02-13 | -$2.00K derived: sum of 3 quarters · filed 2025-02-13 | -$7.24M 10-K · filed 2025-02-13 |
| 2023-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $3.00K derived: sum of 2 quarters · filed 2024-10-30 | -$7.24M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$7.24M 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | -$7.24M 10-Q · filed 2024-05-02 | |||
| 2022-09-30 | -$427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$1.10M derived: sum of 2 quarters · filed 2023-10-26 | $5.73M 10-Q · filed 2023-10-26 | |
| 2022-06-30 | -$669.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $6.16M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $6.83M 10-Q · filed 2023-05-04 | |||
| 2021-03-31 | $527.00K 10-Q · filed 2022-05-03 |